Vasamed

Vasamed is a medical technology company specializing in non-invasive diagnostic systems for assessing vascular health and blood flow. The company's flagship product, the SensiLase PAD-IQ Study System, utilizes laser Doppler and skin perfusion pressure (SPP) technologies to evaluate microcirculation and macrocirculation in patients with peripheral artery disease (PAD) and critical limb ischemia (CLI). These tools are primarily used by vascular surgeons, wound care specialists, and podiatrists to predict wound healing potential and determine the necessity of surgical intervention. The technology is particularly valuable for patients with calcified vessels where traditional pressure-based tests are often inaccurate. In 2015, the company's assets were acquired by Vaso Corporation, which continues to support and distribute the technology through its diagnostics division.